Many Medicare Cancer Patients Now Have Much Lower Out-Of-Pocket Costs [Forbes]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Forbes
When people think about the IRA's drug pricing measures, they're more likely to be familiar with the Medicare price negotiation aspect than the redesign of Medicare's outpatient drug benefit. The former entails Medicare's ability to negotiate prices of a select number of drugs. But the prices that apply to the first round of ten pharmaceuticals won't be implemented until next year. It's the wholesale restructuring of the pharmacy benefit that's far more comprehensive and already having an impact on Medicare recipients, especially beneficiaries who prior to 2024 incurred more than $3,300 in annual out-of-pocket costs. These include many cancer patients. Under the IRA law, annual out-of-pocket costs were capped at $3,300 in 2024 and lower still at $2,000 in 2025. Upon enactment of the Medicare Modernization Act in 2006, the federal government health insurance program for seniors and disabled added a prescription drug benefit called Part D. This meant that Medicare beneficiaries who c
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 27% Discount? [Yahoo! Finance]Yahoo! Finance
- IQVIA (NYSE:IQV) was given a new $230.00 price target on by analysts at Barclays PLC.MarketBeat
- Amphastar Announces FDA Approval for Teriparatide Injection [Yahoo! Finance]Yahoo! Finance
- Electronic Clinical Outcome Assessment Solutions Market Projected to Reach USD 5.64 Billion by 2032 at a CAGR of 15.3% - SNS Insider [Yahoo! Finance]Yahoo! Finance
- Healthy Returns: FDA may add its strongest safety warning to Covid vaccines. Here's what to know [CNBC]CNBC
IQV
Earnings
- 10/28/25 - Beat
IQV
Sec Filings
- 12/19/25 - Form 4
- 12/18/25 - Form 144
- 12/9/25 - Form 8-K
- IQV's page on the SEC website